Neuphoria Therapeutics
NASDAQ: NEUP
NYSE
NYSE
Healthcare
Biotechnology
Global Rank
#38345
Country Rank
#4740
Market Cap
13.44 M
Price
7.15
Change (%)
0.00%
Volume
16,201
Neuphoria Therapeutics's latest marketcap:
13.44 M
As of 06/06/2025, Neuphoria Therapeutics's market capitalization has reached $13.44 M. According to our data, Neuphoria Therapeutics is the 38345th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 13.44 M |
| Revenue (ttm) | 15.66 M |
| Net Income (ttm) | 5.83 M |
| Shares Out | 1.88 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 06/17/2025 |
Market Cap Chart
Data Updated: 06/06/2025
Neuphoria Therapeutics's yearly market capitalization.
Neuphoria Therapeutics has seen its market value grow from $5.58 M to $13.44 M since 2024, representing a total increase of 140.82% and an annual compound growth rate (CAGR) of 667.25%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/06/2025 | $13.44 M | 140.82% |
| 12/31/2024 | $5.58 M |
Company Profile
Neuphoria Therapeutics was founded in 1996 in United States.
on the Nasdaq Stock Market.
With 24 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Neuphoria Therapeutics's (NEUP) current market cap?As of 06/06/2025, Neuphoria Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $13.44 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Neuphoria Therapeutics (NEUP) rank globally by market cap?Neuphoria Therapeutics global market capitalization ranking is approximately 38345 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.